PRECISION BIOSCIENCES INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
PRECISION BIOSCIENCES INC (DTIL) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.58, a 60.27% decline year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $1.46, a 23.96% decline year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $1.92, a 120.69% increase year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.00.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $9.59, a 72.70% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $35.13, a 933.24% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | ||||
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 | $166.04 10-K · filed 2025-03-26 | |||
| 2023-12-31 | $9.59 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | $0.58 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | $0.58 10-Q · filed 2023-08-04 | ||||
| 2023-03-31 | $0.58 10-Q · filed 2023-05-09 | ||||
| 2022-12-31 | $35.13 10-K · filed 2024-03-27 | $1.17 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $1.17 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | $1.22 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | $1.46 10-Q · filed 2022-05-09 | ||||
| 2021-12-31 | $3.40 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $3.25 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | $1.84 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | $1.92 10-Q · filed 2021-05-13 | ||||
| 2020-12-31 | $0.49 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $0.41 10-Q · filed 2020-11-10 | ||||
| 2020-06-30 | $0.37 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | $0.87 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | $1.34 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $0.99 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $1.01 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $0.73 10-Q · filed 2019-04-29 | ||||
| 2018-12-31 | $0.78 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |